October 8th, Guolonghui | Bernstein: Upgraded Humana's rating from "in line with the market" to "outperforming the market", and reduced the target price from $405 to $308.
伯恩斯坦下调Humana目标价至308美元
Bernstein lowers Humana's target price to $308.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.